Box score
Clover Biopharmaceuticals, Ltd.
Reported $3.6M sold in a new Form D filed April 29, 2026 (Chengdu, outside the US).
- Biggest raise
- $3.6M filed Apr 29, 2026
- League
- Bio & Health Biotechnology
- Based in
- Chengdu, outside the US
- Season rank
- #399 of 1,121 in the Bio & Health League; #3413 of 10,745 overall (2026)
- Entity
- Corporation
Form D filings since 2024 3
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2026-04-29 | New notice | $3.6M | $3.6M | SEC |
| 2025-04-28 | Amendment | $905K | $905K | SEC |
| 2024-04-12 | New notice | $321K | $321K | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 1856491.
Similar raises, 2026
| # | Company | League | Raised |
|---|---|---|---|
| 1 | BioLineRx Ltd. | Bio & Health | $3.8M |
| 2 | Pluri Inc. | Bio & Health | $3.7M |
| 3 | Conavi Medical Corp. | Bio & Health | $3.5M |
| 4 | Polyrizon Ltd. rookie | Bio & Health | $3.5M |
| 5 | Edesa Biotech, Inc. | Bio & Health | $3.5M |
| 6 | NewcelX Ltd. | Bio & Health | $3.4M |